By Mill Chart
Last update: Jun 23, 2025
NOVARTIS AG-SPONSORED ADR (NYSE:NVS) stands out as a potential value opportunity, identified by our fundamental screening process. The company combines strong profitability and financial health with an attractive valuation, making it worth a closer look for investors seeking undervalued stocks in the healthcare sector.
NOVARTIS scores a 7/10 in valuation, indicating it trades at a reasonable price relative to its fundamentals. Key points include:
With a 9/10 profitability rating, NOVARTIS excels in earnings efficiency:
The company maintains a solid 7/10 health rating, supported by:
While growth is moderate (5/10), NOVARTIS shows stability:
Our Decent Value screener lists more stocks with similar characteristics.
For a deeper dive, review the full fundamental report on NOVARTIS.
This is not investment advice. Always conduct your own research before making investment decisions.
117.97
+1.14 (+0.98%)
Find more stocks in the Stock Screener